EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biocompatibility and Therapeutic Potential of Cinnamoyl‐Diphenylalanine Dipeptide: A Double‐Edged Sword

Efstratios D Sitsanidis, Visa Ruokolainen, Kari Kunnas, Henna Rahkola, Lotta-Riina Sundberg, Maija Vihinen-Ranta, Mika Pettersson iD, Maija Nissinen

Journal of Biomedical Materials Research Part A · 2026-05 · 114 (5)

DOI: 10.1002/jbm.a.70091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 08.05.2026. Verfasst von Efstratios D Sitsanidis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland. Hauptthemen laut MEDLINE: Dipeptides, Biocompatible Materials, Anti-Bacterial Agents, Antineoplastic Agents. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research council of Finland, Jane ja Aatos Erkon Säätiö, Academy of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluates cinnamoyl‐diphenylalanine dipeptide (Cin‐FF), a newly introduced gelator, for its antimicrobial efficacy, biocompatibility, and potential anticancer properties in solution and gel forms. We show that Cin‐FF exhibits antibacterial efficacy in the gel phase (0.2%, w/v), particularly against Escherichia coli , Acinetobacter baumannii , Staphylococcus aureus , and Bacillus subtilis , attributed to its sustained release and high concentration. In contrast, the solution phase has limited antimicrobial effects, particularly at lower concentrations (0.01% and 0.001%, w/v). The cytotoxicity of Cin‐FF was evaluated across five mammalian cell lines: BJ human fibroblasts, SH‐SY5Y neuroblastoma cells, mouse embryonic fibroblasts (MEF), HeLa cervical cancer cells, and Vero monkey kidney epithelial cells. Higher concentrations in the solution (0.1%, w/v) and in the gel phase (0.2%, w/v) are notably cytotoxic, particularly in the gel form. Lower concentrations in the solution form (0.01% and 0.001%, w/v) initially supported cell viability but induced delayed cytotoxicity by Day 4. Importantly, Cin‐FF demonstrated potent cytotoxic effects against cancerous cell lines (HeLa and SH‐SY5Y), suggesting its potential as a localized anticancer therapy. While Cin‐FF in gel form shows considerable potential for both antimicrobial and anticancer applications, its cytotoxicity toward the noncancerous cells underscores the need for careful dosage control, formulation strategies, and targeted delivery to optimize therapeutic efficacy while minimizing harm to healthy tissues. This paves the way for further development as a multifunctional therapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipeptidesBiocompatible MaterialsAnti-Bacterial AgentsAntineoplastic AgentsPhenylalanineMaterials TestingCinnamatesAnimalsHumansChlorocebus aethiopsMiceVero CellsHeLa CellsBacteriaMicrobial Sensitivity TestsCell SurvivalCell Line

Substanzen

DipeptidesBiocompatible MaterialsAnti-Bacterial AgentsAntineoplastic AgentsPhenylalanineCinnamates

Autor:innen und Institutionen

  • Department of Chemistry, Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland.
  • Department of Biological and Environmental Sciences, Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland.
  • Disease Networks Research Unit, Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland.

ORCID-Profile: Mika Pettersson

Förderung

  • Research council of Finland
  • Jane ja Aatos Erkon Säätiö
  • Academy of Finland

Zitieren

APA

Sitsanidis, E. D., Ruokolainen, V., Kunnas, K., Rahkola, H., Sundberg, L. R., Vihinen-Ranta, M., Pettersson, M., & Nissinen, M. (2026). Biocompatibility and Therapeutic Potential of Cinnamoyl‐Diphenylalanine Dipeptide: A Double‐Edged Sword. Journal of Biomedical Materials Research Part A, 114(5). https://doi.org/10.1002/jbm.a.70091

Vancouver

Sitsanidis ED, Ruokolainen V, Kunnas K, Rahkola H, Sundberg LR, Vihinen-Ranta M, et al. Biocompatibility and Therapeutic Potential of Cinnamoyl‐Diphenylalanine Dipeptide: A Double‐Edged Sword. Journal of Biomedical Materials Research Part A. 2026;114(5). doi:10.1002/jbm.a.70091

BibTeX
@article{Sitsanidis2026,
  author = {Sitsanidis, Efstratios D and Ruokolainen, Visa and Kunnas, Kari and Rahkola, Henna and Sundberg, Lotta-Riina and Vihinen-Ranta, Maija and Pettersson, Mika and Nissinen, Maija},
  title = {Biocompatibility and Therapeutic Potential of Cinnamoyl‐Diphenylalanine Dipeptide: A Double‐Edged Sword},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  volume = {114},
  number = {5},
  doi = {10.1002/jbm.a.70091}
}
Kostenlos starten →